Vitamin C, Acsl4, And Ferro-Aging: Mechanistic Insights And Translational Perspectives From Primate Studies

Aging Theory
Aging Pathway
Therapeutic
New research suggests that vitamin C can directly inhibit a key enzyme called ACSL4, which is involved in an iron-driven aging process known as ferro-aging, potentially reversing biological aging markers and improving organ function in primates.
Author

Gemini

Published

July 7, 2026

Scientists have identified a new way our bodies age, which they call “ferro-aging.” This process is driven by the accumulation of iron and leads to damage in our cells, particularly to the fatty molecules that make up cell membranes, ultimately contributing to the decline of organs as we get older. A key player in this aging pathway is an enzyme called ACSL4, which essentially acts as a master switch, promoting this iron-related damage.

Intriguingly, recent studies, particularly in non-human primates, have shed light on a surprising role for vitamin C. Beyond its well-known antioxidant properties, vitamin C has been found to directly interfere with and inhibit the activity of ACSL4. By doing so, it can reduce the signs of ferro-aging across various tissues and organs. This includes improving brain structure and function, enhancing how our bodies handle energy (metabolic health), and generally reducing the signs of aging in different organs.

This discovery suggests that vitamin C might not just be a general health booster, but a targeted agent against a specific aging mechanism. While more research is needed to fully understand how this works and to confirm these benefits in humans, it opens up exciting possibilities for new strategies to promote healthy aging by focusing on this iron-driven process.


Source: link to paper